🇺🇸 FDA
Patent

US 7598077

Compositions and methods for enhancing differential expression

granted A61KA61K38/00A61K48/00

Quick answer

US patent 7598077 (Compositions and methods for enhancing differential expression) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/00, A61K48/00